PRESENTATION
Q3 2026 — Presentation
Q3 2026PDF · 19 pages3.6 MB
Investor Presentation Q3 2026 © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 1 of 19 -- Cautionary note on forward-looking statements This presentation contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things: future operating and financial performance, product development, and market position and business strategy. The reader is cautioned not to rely on these forward-looking statements. They are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Intuitive Surgical, Inc. Risks and uncertainties include, but are not limited to: macroeconomic factors, which could have a materially adverse impact on our business, financial condition, or results of operation; reliance on sole- and single-source suppliers and inability to purchase at acceptable prices a sufficient supply of materials, parts, and components; public health crises or epidemic diseases; litigation, investigations, or other legal proceedings; the highly competitive nature of our industry, including customers’ preference for competitors’ products or services; market acceptance of our products; inability of hospitals to obtain coverage and reimbursement for procedures using our products or insufficient reimbursement to cover the costs of purchasing our products; defects in or performance problems of our products, which may result in recalls; significant, uninsured losses; the loss of key personnel or inability to attract and retain other personnel; negative publicity concerning our products or company; and long and variable capital sales cycles and seasonality in our business. A further list and descriptions of these risks, uncertainties, and other factors can be found in Intuitive’s Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Intuitive’s subsequent Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission. Copies of these filings are available at www.sec.gov, isrg.intuitive.com, and on request from Intuitive. Any forward-looking statements in this presentation speak only as of the date of this presentation. Intuitive does not undertake to update any forward-looking statements as a result of new information or future events or developments. Some products discussed in this presentation may not be available without regulatory clearance. Please check with your local regulatory contact for current status. © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 2 of 19 -- Our mission We believe that minimally invasive care is life- enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. Our vision We envision a future of care that is less invasive and profoundly better, where diseases are identified early and treated quickly so patients can get back to what matters most. Purpose Value Innovative Transformative Commitment © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 3 of 19 -- Length of stay Consistency of outcomes Surgical site infections Complications Readmission Recovery Conversions Outpatient vs. inpatient Ecosystem support Ergonomics OR / staffing efficiencies Analytics Training Total clinical cost Direct costs Clinical variation Enablement of MIS reproducibility Access to technology and innovations Education and empowerment Improve clinical outcomes Enhance patient experience Improve care team experience Lower total cost of care Expand access to care Where we are focused with our customers © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 4 of 19 -- Source: Intuitive 2025 earnings; 1. As of Dec. 2025. Procedures performed using Intuitive systems includes da Vinci and Ion; 2. As of Nov. 2025. 3.2M+ Procedures performed on Intuitive systems in 2025 20.4M+ Procedures performed on Intuitive systems to date 1 1,900+ Intuitive systems placed in 2025 12,000+ Intuitive systems in hospitals globally 1 3.0M+ Multiport 55K+ Single port 140K+ Ion 19.9M+ Multiport 130K+ Single port 325K+ Ion 1,610+ Multiport 100+ Single port 190+ Ion 10,720+ Multiport 370+ Single port 990+ Ion 4,000+ Peer-reviewed articles published in 20252 48,000+ Peer-reviewed articles published to date 2 © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 5 of 19 -- Worldwide capital trends 200 400 600 800 1,000 1,200 1,400 1,600 1,800 2,000 2020 2021 2022 2023 2024 2025 System placements 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 11,000 12,000 2020 2021 2022 2023 2024 2025 Installed base Greenfield/Incremental Trade-in Rest-of-world Asia United States Europe 2022 2021 +12% YoY 6 Source: Intuitive 2025 earnings. *da Vinci only 2023 2024 2022 2021 2023 2024 2020 2020 2025 2025 © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 6 of 19 -- +21% YoY $1,000 $2,000 $3,000 $4,000 $5,000 $6,000 $7,000 $8,000 $9,000 $10,000 $11,000 2017 2018 2019 2020 2021 2022 2023 2024 2025 Revenue trend (USD, in millions) Non-recurring Recurring 79% 2018 2019 2020 2021 2022 2023 2017 71% 71% 72% 77% 75% 83% 7 Source: Intuitive 2025 earnings; 1. Ranges listed are approximate, not all prices will fall within the range. 84% 2024 Instruments and accessories1 $900 – $3,700 per da Vinci procedure Services1 $95K – $225K per year for da Vinci Surgical Systems Operational leases1 Fixed-payment or usage-based System sale or sales-type lease1 $0.6M – $3.1M per da Vinci Surgical System 84% 2025 © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 7 of 19 -- Da Vinci platforms © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 8 of 19 -- Da Vinci Multi-port Source: Intuitive 2025 earnings. 2020 2021 2022 2023 2024 2025 Procedures 17% YoY Growth 1.2M+ 3.0M+ Installed base 12% YoY Growth 2020 2021 2022 2023 2024 2025 10.7K+ 5.9K+ Utilization 3% YoY Growth 2020 2021 2022 2023 2024 2025 210+ 300+ © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 9 of 19 -- A strong da Vinci 5 launch with clearances in the U.S., Korea, Japan, and Europe Source: Intuitive 2025 earnings. As of Dec. 2025. *Utilization calculated as Q4 2025 estimate in the US. 270,000+ Procedures performed to date 1,200+ Systems installed globally 10,400+ Surgeons using da Vinci 5 11% Higher utilization than Xi* © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 10 of 19 -- Da Vinci SP Source: Intuitive 2025 earnings. 2020 2021 2022 2023 2024 2025 Procedures 87% YoY Growth 5K+ 55K+ Installed base 39% YoY Growth 2020 2021 2022 2023 2024 2025 370+ 60+ Utilization 29% YoY Growth 2020 2021 2022 2023 2024 2025 110+ 180+ © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 11 of 19 -- Ion © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 12 of 19 -- Installed base 24% YoY Growth 2020 2021 2022 2023 2024 2025 990+ 30+ Ion Source: Intuitive 2025 earnings. 2020 2021 2022 2023 2024 2025 Procedures 51% YoY Growth 1K+ 140K+ Utilization 9% YoY Growth 2020 2021 2022 2023 2024 2025 80+ 160+ © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 13 of 19 -- Q3’26 Results © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 14 of 19 -- 14% Da Vinci Procedure growth Y/Y 12% Da Vinci Installed base growth Y/Y 546 Da Vinci systems placed Q3 2026 Results $3.05 Billion in revenue (22% Y/Y) 69.9% Non-GAAP gross margin $3.00 Non-GAAP EPS © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 15 of 19 -- Da Vinci System Installed Base 16 12,094 Worldwide as of September 30, 2026 6,807 United States 2,436 Europe 2,176 Asia 675 Rest of World © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 16 of 19 -- 04 Innovation to reach more patients Advance early-stage R&D programs for new disease states; expand line of sight. 2026 priorities Accelerate access to and quality of minimally invasive care 01 Platform growth Global expansion of da Vinci 5, SP, and Ion. Follow-on digital feature releases and ecosystem enhancements. 02 Procedure adoption Focus procedure growth by country through training, commercial activities, and market access efforts. 03 Quality and manufacturing Continued focus on product quality, building industrial scale, and optimizing manufacturing operations. © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 17 of 19 -- Corporate Impact Outcomes-focused innovation to enhance physician and care team performance, efficiency, and to improve patient outcomes are at the core of what Intuitive does as a business. It is also a vital alignment for our environmental sustainability, social responsibility, and governance transparency work. View 2025 Corporate Impact Report on our website › © 2026 Intuitive Surgical Operations, Inc. All rights reserved. -- 18 of 19 -- -- 19 of 19 --